Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Market Cap	80.39M +91.8%
Revenue (ttm)	35.40M +25.4%
Net Income	7.25M +103.1%
EPS	0.20 +102.9%
Shares Out	36.00M
PE Ratio	11.09
Forward PE	n/a
Dividend	0.03 (1.27%)
Ex-Dividend Date	Apr 16, 2026

Volume	970
Average Volume	5,134
Open	3.200
Previous Close	2.975
Day's Range	3.150 - 3.200
52-Week Range	1.775 - 3.200
Beta	-0.04
RSI	86.38
Earnings Date	Apr 15, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers over the counter, prescription pharmaceutical, and nutritional supplements products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices...

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Employees: 531
• Stock Exchange: Palestine Stock Exchange
• Ticker Symbol: JPH

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $49.93 million, an increase of 25.39% compared to the previous year's $39.82 million. Earnings were $10.23 million, an increase of 103.10%.

Financial numbers in USD